Hyperkalaemia and impaired renal function in patients taking spironolactone for congestive heart failure: retrospective study

被引：53

作者：

Svensson, M

Gustafsson, F

Galatius, S

Hildebrandt, PR

Atar, D ^{[1
]}

机构：

[1] Aker Univ Hosp, Div Cardiol, Oslo, Norway

[2] Frederiksberg Univ Hosp, Dept Cardiol & Endocrinol, DK-2000 Copenhagen, Denmark

来源：

BRITISH MEDICAL JOURNAL | 2003年 / 327卷 / 7424期

关键词：

D O I：

10.1136/bmj.327.7424.1141

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

收藏

页码：1141 / 1142

页数：2

相关论文

共 5 条

[1] GALATIUS S, 2002, AM HEART J S, V144, pS2
[2] GREENBERG B, 2002, J CARDIOVASC PHARM, V38, P59
[3] Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
Pitt, B
Remme, W
Zannad, F
Neaton, J
Martinez, F
Roniker, B
Bittman, R
Hurley, S
Kleiman, J
Gatlin, M
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (14) : 1309 - 1321
[4] The effect of spironolactone on morbidity and mortality in patients with severe heart failure
Pitt, B
Zannad, F
Remme, WJ
Cody, R
Castaigne, A
Perez, A
Palensky, J
Wittes, J
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (10) : 709 - 717
[5] Comprehensive guidelines for the diagnosis and treatment of chronic heart failure - Task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology
Remme, WJ
Swedberg, K
[J]. EUROPEAN JOURNAL OF HEART FAILURE, 2002, 4 (01) : 11 - 22